{"schema_version":"secwatch.filing_event.v1","accession":"0001818093-22-000166","form_type":"8-K","ticker":"SKIN","cik":"0001818093","company_name":"SkinHealth Systems Inc.","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.293330+00:00","generated_at":"2026-06-22T04:23:06.381846+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BeautyHealth Q3 net sales $88.8M (+30% YoY), raises FY net sales guidance; cuts EBITDA outlook","bullets":["Net sales $88.8M (+30% YoY), seventh consecutive beat; raised FY2022 net sales guidance to $360-365M.","GAAP net income $0.1M vs loss $215.1M a year ago; adjusted net income $8.0M.","Adjusted EBITDA $16.5M (18.6% margin); FY2022 adjusted EBITDA guidance revised to $45-50M due to FX and China zero-COVID.","Americas net sales $58.4M (+30% YoY); APAC $15.1M (+44%); EMEA $15.3M (+21%).","Year-to-date delivery systems sold (6,447) already exceed full-year 2021 record of 6,191; total install base 24,473."],"urls":{"canonical":"https://secwatch.observer/filing/0001818093-22-000166","json":"https://secwatch.observer/filing/0001818093-22-000166.json","markdown":"https://secwatch.observer/filing/0001818093-22-000166.md","text":"https://secwatch.observer/filing/0001818093-22-000166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/0001818093-22-000166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/skin-20221108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T04:23:06.381846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"169aeeb2a0aa60711c7bd04aaae1c1e75ba13793","claim":"SkinHealth Systems Inc. updated its third quarter ended September 30, 2022 guidance (raised).","evidence_excerpt":"BeautyHealth Reports Third Quarter 2022 Financial Results Net sales beat expectations for seventh consecutive quarter Company raises 2022 net sales guidance on continued momentum and strong demand, revises adjusted EBITDA guidance against a complex macro backdrop Long Beach, Calif., November 8, 2022 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/0001818093-22-000166-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b19d907939cdff9ed8cfc99e300a8b16032b79fe","claim":"SkinHealth Systems Inc. reported full year 2022 results: revenue $360 million to $365 million. Guidance raised.","evidence_excerpt":"On continued momentum and strong provider and consumer demand, the Company raised its 2022 net sales guidance to $360 million to $365 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/0001818093-22-000166-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2022"},{"label":"Revenue","value":"$360 million to $365 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}